It's long been known that use of a renin-angiotensin-aldosterone system (RAAS) antagonist slows the progression of kidney disease and specifically slows progression of advanced kidney disease, ...

There is "little, if any, clinical reason" to use angiotensin-converting enzyme (ACE) inhibitors for the treatment of hypertension or other cardiovascular indications because angiotensin receptor ...

Since the introduction of ARBs, the question that has pervaded each clinician’s mind is whether or not these drugs serve an advantage in conditions long addressed by ACE inhibitors. Matchar et al ...

Data from this Australian study showed a higher prevalence of intracranial aneurysms (ICAs) in patients with ADPKD compared with the general population. Many patients in the study had no known risk ...

(HealthDay News) — Angiotensin receptor blockers (ARBs) are just as effective and safe as angiotensin-converting enzyme inhibitors (ACEIs), according to research published in Mayo Clinic Proceedings.

NEW YORK (Reuters Health) - The risk of angioedema -- localized swelling in the deep layers of the skin that usually affects the face, throat, lips or tongue -- is more than 3 times higher with a ...

ACE inhibitors that can cross the blood-brain barrier may help prevent dementia, according to findings presented at the American Geriatrics Society meeting in Seattle in May. Using data from a larger, ...

Please provide your email address to receive an email when new articles are posted on . There was a significant independent link between angiotensin-converting enzyme inhibitor use and all-cause ...

Angiotensin-converting enzyme inhibitors (ACEi) are the leading cause of drug-induced angioedema in the USA, with an incidence of 0.1–0.7%. While ACEi-induced angioedema (ACEi-AE) typically affects ...